Physician profile
Mark W Cummings
NPI 1578785556
$530.76
in general payments reported to CMS, 2019-2025
13 companies · $103 in 2025
The $103 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.25 · 2020: $17.08 · 2021: $45.57 · 2022: $79.54 · 2023: $126 · 2024: $144 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $125.79 | 2020-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $107.18 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi-Aventis U.S. LLC | $53.51 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $53.28 | 2024 | |
| Tris Pharma INC | $48.08 | 2022-2023 | Dyanavel Xr |
| Corium, LLC | $27.17 | 2023 | Azstarys |
| Alk-Abello, INC | $24.84 | 2025 | Neffy |
| Ultragenyx Pharmaceutical INC. | $17.63 | 2021 | |
| Biogen, INC. | $16.26 | 2021 | |
| Iscreen Vision INC. | $15.25 | 2019 | |
| Pfizer INC. | $14.48 | 2024 | |
| Sanofi Pasteur INC. | $14.36 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $12.93 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.